Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
|||
Line 85: | Line 85: | ||
|- | |- | ||
| [[Media:QIBA PDFF Profile Stage2 FINAL.pdf| MR MRI-Based Proton Density Fat Fraction (PDFF) of the Liver 2023-12-04]] | | [[Media:QIBA PDFF Profile Stage2 FINAL.pdf| MR MRI-Based Proton Density Fat Fraction (PDFF) of the Liver 2023-12-04]] | ||
− | | | + | |Consensus |
|2023.09.08 | |2023.09.08 | ||
|Public Comment Resolutions 2023-11-14 | |Public Comment Resolutions 2023-11-14 | ||
Line 131: | Line 131: | ||
| Clinically Feasible | | Clinically Feasible | ||
| 2023.12.13 | | 2023.12.13 | ||
− | | [[Media: | + | | [[Media:2023 12 13 SWS BC QIBA Technical Confirmation Resolutions.xlsx| Clinically Feasible Comment Resolutions 2023-12-13]] |
|- | |- | ||
− | | [[Media:SWS Profile Final | + | | [[Media:SWS Profile Final Candidate February 07 2023 CLEAN.pdf|US Shear Wave Speed for Liver Fibrosis 2023-02-07, clean version]] |
| Clinically Feasible | | Clinically Feasible | ||
| 2023.12.13 | | 2023.12.13 | ||
− | | [[Media: | + | | [[Media:2023 12 13 SWS BC QIBA Technical Confirmation Resolutions.xlsx| Clinically Feasible Comment Resolutions 2023-12-13]] |
|- | |- | ||
| [[Media:QIBA US VBF Profile 2023-12-13-tracked-changes.pdf|US Volume Blood Flow (VBF) Profile 2023-12-13 (tracked changes)]] | | [[Media:QIBA US VBF Profile 2023-12-13-tracked-changes.pdf|US Volume Blood Flow (VBF) Profile 2023-12-13 (tracked changes)]] | ||
| Consensus | | Consensus | ||
| 2023.12.13 | | 2023.12.13 | ||
− | | [[Media: | + | | [[Media:2023 12 13 VBF BC QIBA Consensus Confirmation Resolutions.xlsx| Consensus Comment Resolutions 2023-12-13]] |
|- | |- | ||
|} | |} |
Revision as of 14:40, 21 December 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.